This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1992 Jul 1;84(13):1039-40.

doi: 10.1093/jnci/84.13.1039.

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer

J S Lee¹, H I Libshitz, F V Fossella, W K Murphy, A C Pang, S M Lippman, D M Shin, I W Dimery, B S Glisson, W K Hong

Affiliations

PMID: 1318977
DOI: 10.1093/jnci/84.13.1039

Clinical Trial

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer

J S Lee et al. J Natl Cancer Inst. 1992.

. 1992 Jul 1;84(13):1039-40.

doi: 10.1093/jnci/84.13.1039.

Authors

J S Lee¹, H I Libshitz, F V Fossella, W K Murphy, A C Pang, S M Lippman, D M Shin, I W Dimery, B S Glisson, W K Hong

Affiliation

¹ Department of Medical Oncology, UT M. D. Anderson Cancer Center, Houston 77030.

PMID: 1318977
DOI: 10.1093/jnci/84.13.1039

No abstract available

PubMed Disclaimer

Similar articles

Alleviation by leucovorin of the dose-limiting toxicity of edatrexate: potential for improved therapeutic efficacy.
Lee JS, Murphy WK, Shirinian MH, Pang A, Hong WK. Lee JS, et al. Cancer Chemother Pharmacol. 1991;28(3):199-204. doi: 10.1007/BF00685509. Cancer Chemother Pharmacol. 1991. PMID: 1649705
Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.
Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. Cancer. 1991 Sep 1;68(5):959-64. doi: 10.1002/1097-0142(19910901)68:5<959::aid-cncr2820680508>3.0.co;2-v. Cancer. 1991. PMID: 1655220 Clinical Trial.
Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.
Laurie SA, Pfister DG, Kris MG, Tong WP, Chronowski G, Pisters KM, Heelan RT, Sirotnak FM. Laurie SA, et al. Clin Cancer Res. 2001 Mar;7(3):501-9. Clin Cancer Res. 2001. PMID: 11297240 Clinical Trial.
Edatrexate studies in non-small cell lung cancer.
Gralla RJ. Gralla RJ. Lung Cancer. 1995 Apr;12 Suppl 1:S187-91. doi: 10.1016/0169-5002(95)00435-4. Lung Cancer. 1995. PMID: 7551928 Review.
Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
Holmes FA. Holmes FA. Semin Oncol. 1996 Oct;23(5 Suppl 11):46-56. Semin Oncol. 1996. PMID: 8893900 Review.

See all similar articles

Cited by

Promising new agents in the treatment of non-small cell lung cancer.
Edelman MJ, Gandara DR. Edelman MJ, et al. Cancer Chemother Pharmacol. 1996;37(5):385-93. doi: 10.1007/s002800050402. Cancer Chemother Pharmacol. 1996. PMID: 8599859 Review.
Effective combination therapy of metastatic murine solid tumors with edatrexate and the vinca alkaloids, vinblastine, navelbine and vindesine.
Otter GM, Sirotnak FM. Otter GM, et al. Cancer Chemother Pharmacol. 1994;33(4):286-90. doi: 10.1007/BF00685901. Cancer Chemother Pharmacol. 1994. PMID: 8281620
Preemptive leucovorin administration minimizes pralatrexate toxicity without sacrificing efficacy.
Koch E, Story SK, Geskin LJ. Koch E, et al. Leuk Lymphoma. 2013 Nov;54(11):2448-51. doi: 10.3109/10428194.2013.779688. Epub 2013 Apr 8. Leuk Lymphoma. 2013. PMID: 23442065 Free PMC article.
Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitro.
Chou TC, Otter GM, Sirotnak FM. Chou TC, et al. Cancer Chemother Pharmacol. 1996;37(3):222-8. doi: 10.1007/BF00688320. Cancer Chemother Pharmacol. 1996. PMID: 8529281

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information